These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38313521)

  • 1. Computational Approach to Elucidating Insulin-Protamine Binding Interactions and Dynamics in Insulin NPH Formulations.
    Rohilla KK; Pandey MK
    ACS Omega; 2024 Jan; 9(4):4857-4869. PubMed ID: 38313521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of insulin NPH formulations.
    Norrman M; Hubálek F; Schluckebier G
    Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of Protamine and Zn-Insulin Assembly: Exploring Biophysical Consequences.
    Aggarwal S; Tanwar N; Singh A; Munde M
    ACS Omega; 2022 Nov; 7(45):41044-41057. PubMed ID: 36406544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions.
    Rahuel-Clermont S; French CA; Kaarsholm NC; Dunn MF; Chou CI
    Biochemistry; 1997 May; 36(19):5837-45. PubMed ID: 9153424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.
    Dodd SW; Havel HA; Kovach PM; Lakshminarayan C; Redmon MP; Sargeant CM; Sullivan GR; Beals JM
    Pharm Res; 1995 Jan; 12(1):60-8. PubMed ID: 7724489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
    Zöllner H; Jouni R; Panzer S; Khadour A; Janzen L; Wesche J; Ten Berg M; Schellong S; Heinken A; Greinacher A; Bakchoul T
    J Thromb Haemost; 2017 Jan; 15(1):176-184. PubMed ID: 27759896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations of Albumin-Insulin Detemir Complexes Using Molecular Dynamics Simulations and Free Energy Calculations.
    Ryberg LA; Sønderby P; Bukrinski JT; Harris P; Peters GHJ
    Mol Pharm; 2020 Jan; 17(1):132-144. PubMed ID: 31790268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the R-state insulin hexamer and its derivatives. The hexamer is stabilized by heterotropic ligand binding interactions.
    Brader ML; Kaarsholm NC; Lee RW; Dunn MF
    Biochemistry; 1991 Jul; 30(27):6636-45. PubMed ID: 2065051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
    Yip CM; Brader ML; Frank BH; DeFelippis MR; Ward MD
    Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protamine antibody production in diabetic subjects treated with NPH insulin.
    Ellerhorst JA; Comstock JP; Nell LJ
    Am J Med Sci; 1990 May; 299(5):298-301. PubMed ID: 2337121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J; Schreyen H; Dorchy H
    Diabete Metab; 1992; 18(4):272-6. PubMed ID: 1459314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
    Rezvani S; Ebadi A; Razzaghi-Asl N
    J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluronic
    Sultan MH; Mahdi WA; Kwon YM
    Bioimpacts; 2021; 11(1):59-64. PubMed ID: 33469509
    [No Abstract]   [Full Text] [Related]  

  • 15. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations.
    Vincent GM; Janowski M; Menlove R
    Cathet Cardiovasc Diagn; 1991 Jul; 23(3):164-8. PubMed ID: 1831070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.
    Stewart WJ; McSweeney SM; Kellett MA; Faxon DP; Ryan TJ
    Circulation; 1984 Nov; 70(5):788-92. PubMed ID: 6488493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.
    Xue Y; Yuwen T; Zhu F; Skrynnikov NR
    Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Insulin Lispro Protamine Suspension with NPH Insulin in Pregnant Women with Type 2 and Gestational Diabetes Mellitus: Maternal and Perinatal Outcomes.
    Colatrella A; Visalli N; Abbruzzese S; Leotta S; Bongiovanni M; Napoli A
    Int J Endocrinol; 2013; 2013():151975. PubMed ID: 23840206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
    Yanagisawa K
    Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.